Actinogen CEO assumes Managing Director position
Filed with ASX · · 2 pages · English
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Actinogen appoints Dr Steven Gourlay as CEO
- ACW raises an addtional $3.55m under a Shortfall Placement
- Resignation of Dr Bill Ketelbey as Chief Executive Officer
- FDA Grants ACW Rare Paediatric Disease Designation in FXS
- Completion of Entitlement Offer
Later from Actinogen Medical
- Strategic Update & Teleconference Call Notification
- Response to ASX Price Query
- Actinogen Ethics Committee approval for XanaMIA study
- Clinical progress for XanaMIA trial
- Actinogen receives positive Pre-IND FDA advice for FXS
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical